Cure My Disease

Don't miss your cure!

 Log in / Sign up

New diabetes drug candidate tested in healthy people

NCT ID NCT07588906

Completed Knowledge-focused Sponsor: Jiangsu HengRui Medicine Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-phase trial tested a single injection of a new drug called SHR-3167 alongside standard insulin glargine in 24 healthy men. The goal was to compare how the drugs affect blood sugar and how the body processes them. The study focused on safety and basic drug behavior, not on treating any disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SHR-3167 injection and insulin glargine
What this could lead to
If successful, this could help develop a new insulin-like drug for diabetes management.
What could go wrong
This is a very early, small study in healthy people, not those with diabetes. The drug may not work as hoped in patients or could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY SUBJECTS

Contacts and locations

Locations

  • Bishan Hospital of Chongqing

    Chongqing, Chongqing Municipality, 400000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.